本文已被:浏览 217次 下载 227次
Received:February 10, 2026 Published Online:October 23, 2026
Received:February 10, 2026 Published Online:October 23, 2026
中文摘要: 脑心综合征(CCS)又称卒中-心脏综合征,其本质是脑部疾病与心脏功能相互作用的复杂临床综合征。近年来,随着对CCS机制的深入探索,新的病理生理机制如肠道菌群-脑-心轴、中性粒细胞胞外陷阱(NETs)及线粒体自噬异常等被发现,为CCS的临床治疗提供了新思路。由于脑部病变症状易掩盖心脏的异常、缺乏特异性诊断指标,且患者常合并心脑血管基础病导致鉴别困难,临床实践中对CCS机制认知尚不充分,诊断缺乏统一标准,治疗手段相对有限。本文从CCS的病理生理机制、诊断及治疗等方面对CCS的研究进展进行系统综述。
Abstract:Cerebrocardiac syndrome(CCS),also known as stroke-heart syndrome,is a complex clinical syndrome defined by the pathophysiological interactions between cerebral disorders and cardiac function. In recent years,in-depth investigations into CCS mechanisms have identified novel pathophysiological pathways,including the gut microbiota-brain-heart axis,neutrophil extracellular traps(NETs)and abnormal mitophagy,providing new insights for the clinical management of CCS. The diagnosis of CCS remains challenging in clinical practice:neurological symptoms frequently overshadow cardiac abnormalities,specific diagnostic biomarkers are lacking,and pre-existing cardiovascular and cerebrovascular comorbidities further complicate differential diagnosis. In addition,clinical understanding of CCS mechanisms is still insufficient,unified diagnostic criteria have not been established,and therapeutic options remain relatively limited. This article presents a systematic review of research advances in CCS,covering its pathophysiological mechanisms,diagnostic strategies and therapeutic modalities.
keywords: Cerebrocardiac syndrome Ischemic stroke Myocardial injury Gut-brain-heart axis Neutrophil extracellular traps Mitophagy
文章编号: 中图分类号:R541 R743 文献标志码:A
基金项目:山东省自然科学基金项目(ZR2024MH098);山东省中医药科技项目(ZR20244405);济宁市重点研发计划 (2024YXNS238)
引用文本:
